PAMA - G2 Intelligence

OIG Medicare Lab Spending Report May Warn of Greater Scrutiny of Genetic and Automated Chemistry Tests

OIG Medicare Lab Spending Report May Warn of Greater Scrutiny of Genetic and Automated Chemistry Tests

by Glenn S. Demby | Aug 29, 2020 | Articles, CMS-lca, Essential, Lab Compliance Advisor, Reimbursement-lca

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

The 6 Hottest Lab Compliance Stories That Almost Nobody Is Paying Attention To

by Glenn S. Demby | Jul 20, 2020 | Articles, Essential, Focus On-nir, National Lab Reporter

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Agency to Review First Two Years of PAMA-Based Medicare Reimbursements for Lab Tests

Agency to Review First Two Years of PAMA-Based Medicare Reimbursements for Lab Tests

by Glenn S. Demby | Jun 17, 2020 | Articles, Essential, Fee Schedules-nir, National Lab Reporter, OIG-nir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Agency to Review First Two Years of PAMA-Based Medicare Reimbursements for Lab Tests

COVID-19 Relief Bill Defers 2021 Medicare Part B Lab Test Price Cuts for One Year

by Glenn S. Demby | Apr 14, 2020 | Articles, Essential, HIPAA-nir, Legislation-nir, National Lab Reporter, Reimbursement-nir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

COVID-19 Relief Bill Leaves Labs Out in the Cold

COVID-19 Relief Bill Leaves Labs Out in the Cold

by Glenn S. Demby | Mar 30, 2020 | Articles, Essential, Industry Buzz-lir, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

« Older Entries

Next Entries »